Literatur
- 1
Aizenstein H J, Nebes R D, Saxton J A, Price J C, Mathis C A, Tsopelas N D, Ziolko S K,
James J A, Snitz B E, Houck P R, Bi W, Cohen A D, Lopresti B J, DeKosky S T, Halligan E M,
Klunk W E.
Frequent amyloid deposition without significant cognitive impairment
among the elderly.
Arch Neurol.
2008;
65
1509-17
- 2
Bentzen S M.
Theragnostic imaging for radiation oncology: dose-painting by
numbers.
Lancet Oncology.
2005;
6
112-7
- 3
Bremer C.
Optical Methods.
Handb Exp Pharmacol.
2008 ;
(185 Pt 2): )
3-12
- 4
Brooks D J.
Assessment of ParkinsonŽs disease with imaging.
Parkinsonism & Rel
Dis.
2007;
13
S268-S275
- 5
Del Vecchio S, Zannetti A, Fonti R, Pace L, Salvatore M.
Nuclear imaging in cancer theranostics.
Q J Nucl Med
Mol Imaging.
2007;
51
(2)
152-63
- 6
Eschmann S M, Friedel G, Paulsen F, Reimold M, Hehr T, Budach W, Langen H J, Bares R.
18F-FDG PET for assessment
of therapy response and preoperative re-evaluation after neo-adjuvant
radio-chemotherapy in stage III non-small cell lung cancer.
Eur
J Nucl Med Mol I.
2007;
34
463-471
- 7
Funovics M.
Optische Bildgebung von Fluoreszenz im nahen Infrarot. Von passiven
zu enzymatisch aktivierbaren Kontrastmitteln.
Radiologe.
2007;
47
53-61
- 8
Gaenslen A, Unmuth B, Godau J, Liepelt I, Di Santo A, Schweitzer K J, Gasser T, Machulla H J,
Reimold M, Marek K, Berg D.
The specificity and sensitivity of transcranial ultrasound in
the differential diagnosis of ParkinsonŽs disease: a prospective
blinded study.
Lancet Neurol.
2008;
7
417-424
- 9
Gasser T.
Update on the genetics of Parkinson’s disease.
Mov
Disord.
2007;
22 Suppl 17
S343-S350
- 10
Heckl S, Pipkorn R, Waldeck W, Spring H, Jenne J, von
der Lieth C W, Corban-Wilhelm H, Debus J, Braun K.
Intracellular visualization of prostate cancer using magnetic
resonance imaging.
Cancer Res.
2003;
63
(16)
4766-72
- 11
Heckl S, Vogel U.
Nuclear trafficking of a gadolinium
conjugate in nude mice xenografted with human LN-229 glioma.
Pharmacol
Exp Ther.
2006;
319
(2)
657-62
- 12
Judenhofer M S, Wehrl H F, Newport D F. et al .
Simultaneous PET-MRI: a new approach
for functional and morphological imaging.
Nat Med.
2008;
14
(4)
459-65
- 13
Saksena M A, Saokar A, Harisinghani M G.
Lymphotropic nanoparticle enhanced MR imaging
(LNMRI) technique for lymph node imaging.
Eur J Radiol.
2006;
58
(3)
367-74
- 14
Schlemmer H P, Pichler B J, Schmand M, Burbar Z, Michel C, Ladebeck R, Jattke K, Townsend D,
Nahmias C, Jacob P, Heiss W D, Claussen C D.
Simultaneous
MR/PET Imaging of the Human Brain: A Feasibility Study.
Radiology.
2008;
248
(3)
1028-35
- 15
Townsend D W.
Dual-modality imaging: combining anatomy and function.
J
Nucl Med.
2008;
49
(6)
938-55
- 16
Weissleder R and
Pittet MJ.
Imaging in the era of molecular oncology.
Nature.
2008;
452
(3)
580-9
Prof. Dr. med. Dipl.-Phys. Heinz-Peter Schlemmer
Abteilung für
Diagnostische und Interventionelle Radiologie, Radiologische
Klinik, Universitätsklinikum Tübingen
Hoppe-Seyler-Str. 3
72076 Tübingen
Phone: 07071/29-86677 oder -80497, -83220
Fax: 07071/29-5392
Email: heinz-peter.schlemmer@med.uni-tuebingen.de
